FITC-SAHA
FITC-SAHA is SAHA (HY-10221) conjugated with fluorescein. SAHA is an inhibitor of histone deacetylase (HDAC) . FITC-SAHA can be used in cancer and Alzheimer's disease related research[1].
Product Specifications
CAS Number
[1160823-10-8]
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/fitc-saha.html
Smiles
O=C1OC2(C3=CC=C(NC(NCC4=CC=C(NC(CCCCCCC(NO)=O)=O)C=C4)=S)C=C13)C5=CC=C(C=C5OC6=CC(O)=CC=C62)O
Molecular Formula
C36H34N4O8S
Molecular Weight
682.74
References & Citations
[1]Kral AM, et al. Divergent kinetics differentiate the mechanism of action of two HDAC inhibitors. Biochemistry. 2014 Feb 4;53 (4) :725-34.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-164816/FITC-SAHA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-164816/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human PPP1R3F shRNA (UAS) - Lentiviral human PPP1R3F shRNA (UAS) (100)
Recombinant Mouse Calcitonin gene-related peptide type 1 receptor (Calcrl), partial
